Trademark: 79256903
Status Date
Tuesday, February 25, 2020
Registration Number
5993170
Registration Date
Tuesday, February 25, 2020
Filing Date
Wednesday, December 19, 2018
Published for Opposition
Tuesday, December 10, 2019
9 Downloadable computer software, application software, mobile application software, software development tools in the nature of computer software, database software in the nature of computer software for use in database management, all aforementioned goods downloadable and related to the medical field, namely, for researching diagnosing, preventing, combating, treating and monitoring the treatment of diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism
5 Diagnostic agents for pharmaceutical purposes containing chemical preparations, biochemical agents, buffers, and diagnostic reagents, also in the form of kits, for medical purposes in the field of treating diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism
1 Chemical, biochemical and biotechnological products, namely, chemical, biochemical and biotechnological agents used for non-medical purposes, namely, agents for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system; chemical preparations, namely, chemical preparations for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system; biochemical agents, namely, biochemical agents for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system; buffers, namely, buffers for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system
44 Medical services, medical care, medical testing in the nature of medical diagnostic testing; providing information in the field of medical information, namely, in the fields of diagnosing, preventing, combating, treating and monitoring the treatment of diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism
42 Medical and scientific research and analysis services in the nature of quality measurement and analysis for medical practices, and software design and development concerning quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system in the field of researching, diagnosing, preventing, combating, treating, and monitoring the treatment of diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism
Color is not claimed as a feature of the mark.
"RAAS"
Nov 4, 2023
New Representative At Ib Received
Nov 26, 2021
New Representative At Ib Received
Jul 17, 2020
Final Decision Transaction Processed By Ib
Jun 25, 2020
Final Disposition Notice Sent To Ib
Jun 25, 2020
Final Disposition Processed
May 25, 2020
Final Disposition Notice Created, To Be Sent To Ib
Feb 25, 2020
Registered-Principal Register
Dec 10, 2019
Official Gazette Publication Confirmation E-Mailed
Dec 10, 2019
Published For Opposition
Nov 20, 2019
Notification Of Notice Of Publication E-Mailed
Nov 3, 2019
Approved For Pub - Principal Register
Nov 3, 2019
Examiner's Amendment Entered
Nov 3, 2019
Notification Of Examiners Amendment E-Mailed
Nov 3, 2019
Examiners Amendment E-Mailed
Nov 3, 2019
Examiners Amendment -Written
Sep 17, 2019
Notification Of Final Refusal Emailed
Sep 17, 2019
Final Refusal E-Mailed
Sep 17, 2019
Final Refusal Written
Aug 14, 2019
Teas/Email Correspondence Entered
Aug 14, 2019
Correspondence Received In Law Office
Aug 14, 2019
Assigned To Lie
Aug 5, 2019
Teas Response To Office Action Received
Jun 8, 2019
Refusal Processed By Ib
May 22, 2019
Non-Final Action Mailed - Refusal Sent To Ib
May 22, 2019
Refusal Processed By Mpu
Apr 30, 2019
Application Filing Receipt Mailed
Apr 26, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Apr 25, 2019
Non-Final Action Written
Apr 24, 2019
Assigned To Examiner
Apr 24, 2019
New Application Office Supplied Data Entered
Apr 18, 2019
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
